Fosun Pharma

Irina Zhou’s five-year-old cat has gained about a kilogram every year for the past three years. She knows the extra…

The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28…

“Biotechnology is a high-risk field like a ‘molecular casino’,” said founder Alex Zhavoronkov. “Even with artificial intelligence, you can lose…

A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a…